Brief Summary: A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure
Detailed Description: The overall objective is confirmation of BiDils Safety and Efficacy in African-American AFA Patients with Moderate to Severe Symptomatic Heart Failure